The anti-tnf certolizumab pegol in combination with methotrexate is significantly more effective than methotrexate alone in the treatment of patients with active rheumatoid arthritis: Preliminary results from the rapid 1 study

被引：0
|
作者：
Keystone, E. [1 ]
Mason, D. [2 ]
Combe, B.
机构：
[1] Univ Toronto, Toronto, ON, Canada
[2] R&D UCB Inc, Atlanta, GA USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2007年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：55 / 55
页数：1
相关论文
共 50 条
  • [1] Certolizumab pegol in combination with methotrexate is significantly more effective than methotrexate alone in patients with active rheumatoid arthritis: Results from the rapid 1 study
    Bykerk, Vivian
    Mason, David
    Keystone, Edward
    [J]. JOURNAL OF RHEUMATOLOGY, 2008, 35 (06) : 1202 - 1202
  • [2] BONE LOSS IN PATIENTS WITH RHEUMATOID ARTHRITIS: ANTI-TNF AND METHOTREXATE COMPARED WITH METHOTREXATE TREATMENT ALONE
    Vreju, F.
    Ciurea, P.
    Rosu, A.
    Florea, M.
    Musetescu, A.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 322 - 322
  • [3] Efficacy and safety of certolizumab pegol in combination with methotrexate (MTX) in patients with active rheumatoid arthritis despite MTX therapy: Results from the RAPID 2 study
    Smolen, J.
    Brzezicki, J.
    Mason, D.
    Kavanaugh, A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 187 - 188
  • [4] Wutou decoction, in combination with methotrexate, is more effective and equally tolerated, compared to methotrexate alone, in early active rheumatoid arthritis treatment
    Yue, Tao
    Fan, Xiaolei
    Zhang, Zhanming
    Liu, Zhaoyi
    Guo, Mengru
    Wang, Rongsheng
    Bai, Fengmin
    Qin, Yingying
    Wang, Haijun
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (09): : 11930 - 11937
  • [5] Sustained efficacy of certolizumab pegol added to methotrexate in the treatment of rheumatoid arthritis: 2-year results from the RAPID 1 trial
    Keystone, Edward C.
    Combe, Bernard
    Smolen, Josef
    Strand, Vibeke
    Goel, Niti
    van Vollenhoven, Ronald
    Mease, Philip
    Landewe, Robert
    Fleischmann, Roy
    Luijtens, Kristel
    van der Heijde, Desiree
    [J]. RHEUMATOLOGY, 2012, 51 (09) : 1628 - 1638
  • [6] Randomized, Double-blind, Placebo-controlled, Comparative Study of Human Anti-TNF Antibody Adalimumab in Combination with Methotrexate and Methotrexate Alone in Taiwanese Patients with Active Rheumatoid Arthritis
    Chen, Der-Yuan
    Chou, Show-Jan
    Hsieh, Tsu-Yi
    Chen, Yi-Hsing
    Chen, Hsin-Hua
    Hsieh, Chia-Wei
    Lan, Joung-Liang
    [J]. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2009, 108 (04) : 310 - 319
  • [7] Clinical evaluation of tocilizumab for patients with active rheumatoid arthritis refractory to anti-TNF biologics: tocilizumab in combination with methotrexate
    Nakashima, Yasuharu
    Kondo, Masakazu
    Harada, Hiroshi
    Horiuchi, Takahiko
    Ishinishi, Takashi
    Jojima, Hiroshi
    Kuroda, Koji
    Miyahara, Hisaaki
    Nagamine, Ryuji
    Nakashima, Hitoshi
    Otsuka, Takeshi
    Saikawa, Isao
    Shono, Eisuke
    Suematsu, Eiichi
    Tsuru, Tomomi
    Wada, Ken
    Iwamoto, Yukihide
    [J]. MODERN RHEUMATOLOGY, 2010, 20 (04) : 343 - 352
  • [8] Adalimumab plus methotrexate is more effective than adalimumab alone in patients with rheumatoid arthritis (RA) - Results from a longitudinal observational study
    Schrumpf, M
    Rodevand, E
    Mikkelsen, K
    Kaufmann, C
    Didriksen, A
    Mowinckel, P
    Kvien, TK
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 184 - +
  • [9] Adalimumab plus methotrexate or standard therapy is more effective than methotrexate or standard therapies alone in the treatment of fatigue in patients with active, inadequately treated rheumatoid arthritis
    Yount, S.
    Sorensen, M. V.
    Cella, D.
    Sengupta, N.
    Grober, J.
    Chartash, E. K.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2007, 25 (06) : 838 - 846
  • [10] Efficacy of anti-CD20 treatment in patients with rheumatoid arthritis resistant to a combination of methotrexate/anti-TNF therapy
    Bokarewa, M.
    Lindholm, C.
    Zendjanchi, K.
    Nadali, M.
    Tarkowski, A.
    [J]. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2007, 66 (04) : 476 - 483
12345